ABUS compared with OMEX: revenue, margins and what each company keeps, and the suppliers and customers both name

ABUSArbutus Biopharma Corp

Mkt capRevenueRevenue

OMEXOdyssey Marine Exploration Inc

Mkt capRevenueRevenue

Compare

ABUSArbutus Biopharma Corp

OMEXOdyssey Marine Exploration Inc

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

ABUSwithOMEX

No shared trading history for ABUS and OMEX.

Shared co-movers: not yet measured (OMEX).

ABUS, solidOMEX, hatchedr = correlationBar = r to r 0.75Source: daily closes

ABUSArbutus Biopharma Corp

4.01· pre 3.97· delayed

Mkt cap$791.4MRevenue$1MQ2 FY26Revenue$14MFY25

OMEXOdyssey Marine Exploration Inc

12.27· pre 12.06· delayed

Pre-marketNov 2 '26delayed

Mkt cap$28.4MRevenue$108,913Q3 FY26Revenue$353,719FY25

Compare

Pre-marketNov 2 '26delayed

ABUSArbutus Biopharma Corp

OMEXOdyssey Marine Exploration Inc

4.01pre 3.97delayed

Price

12.27pre 12.06delayed

$791.4M

Mkt cap

$28.4M

Q2 FY26$1M

Revenue

$108,913Q3 FY26

FY25$14M

Revenue

$353,719FY25

ABUS4.01vsOMEX12.27Pre-marketNov 2 '26delayed